This antibody is a mouse monoclonal antibody that is capable of binding to HIV-1 p24.
Figure 1 Mouse Anti-HIV-1 p24 Recombinant Antibody (clone AG3.0) (MRO-961CQ) in ELISA.
ELISA analysis of MRO-961CQ was performed by coating with recombinant HIV-1 p24 antigen, His tag.
Figure 2 Mouse Anti-HIV-1 p24 Recombinant Antibody (clone AG3.0) (MRO-961CQ) in WB.
Western blot analysis of MRO-961CQ was performed by loading 0.1 µg (lane 1), 0.3 µg(lane 2), and 0.6 µg (lane 3)recombinant HIV-1 p24 antigen, His tag onto a 12% Tris-HCl polyacrylamide gel.
Figure 3 Mouse Anti-HIV-1 p24 Recombinant Antibody (clone AG3.0) (MRO-961CQ) in Dot Blot.
Dot blot analysis of MRO-961CQ by coating with recombinant HIV-1 p24 antigen, His tag.
Figure 4 Mouse Anti-HIV-1 p24 Recombinant Antibody (clone AG3.0) (MRO-961CQ) in SDS-PAGE.
SDS-PAGE analysis of MRO-961CQ in non-reduced (Lane 1, 1.5 μg) and β-mercaptoethanol-reduced (Lane 2, 1.5 μg) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
Figure 5 Mouse Anti-HIV-1 p24 Recombinant Antibody (clone AG3.0) (MRO-961CQ) in SEC-HPLC.
The purity of MRO-961CQ was 98.17% as determined by SEC-HPLC.
Tada, Takuya, et al. "Prophylaxis and treatment of SARS-CoV-2 infection by an ACE2 receptor decoy in a preclinical animal model." Iscience 26.2 (2023). https://doi.org/10.1016/j.isci.2023.106092
The study conducted by Takuya Tada and colleagues focuses on the development and testing of a high-affinity ACE2 receptor decoy to combat SARS-CoV-2 infection, including variants like Omicron. The decoy, a modified ACE2 ectodomain fused to an immunoglobulin heavy chain Fc region, was shown to significantly suppress virus loads in preclinical animal models. The decoy demonstrated potent neutralizing activity against various SARS-CoV-2 variants, both in vitro and in vivo, by preventing the virus from binding to the ACE2 receptor on host cells. This approach offers a promising prophylactic and therapeutic strategy against current and potentially future SARS-CoV-2 variants, given its ability to target the conserved ACE2 binding mechanism of the virus.
Creative Biolabs played a crucial role in this study by providing the anti-p24 monoclonal antibody AG3.0 (Cat#: MRO-961CQ). This antibody was essential for the virion-decoy pull-down assay, which involved binding decoy proteins to nickel-nitrilotriacetic acid-agarose beads, incubating with spike protein-pseudotyped virus, and analyzing bound virions on an immunoblot. The anti-p24 antibody AG3.0 enabled the detection of bound virions, facilitating the evaluation of the decoy protein's efficacy in neutralizing the virus. This contribution was significant as it provided a key reagent necessary for the successful execution and analysis of the assay.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-186LC | Anti-HIV-1 p24 Recombinant Antibody (6A9/5) | ELISA | Human antibody |
MRO-186LC-S(P) | Anti-HIV-1 p24 Recombinant Antibody scFv Fragment (6A9/5) | ELISA | Human antibody |
MRO-186LC-F(E) | Anti-HIV-1 p24 Recombinant Antibody Fab Fragment (6A9/5) | ELISA | Human antibody |
MRO-187LC-F(E) | Anti-HIV-1 p24 Recombinant Antibody Fab Fragment (6D9/4) | ELISA | Human antibody |
MRO-188LC-F(E) | Anti-HIV-1 p24 Recombinant Antibody Fab Fragment (2E7/3) | ELISA | Human antibody |
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# MRO-961CQ, RRID: AB_3111553)
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.